Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

類似資料

• A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
  著者:: Richardson, Paul G., 等
  出版事項: (2014)
• Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
  著者:: Richardson, Paul G., 等
  出版事項: (2010)
• A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
  著者:: Richardson, Paul G., 等
  出版事項: (2006)
• Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
  著者:: Richardson, Paul, 等
  出版事項: (2010)
• Bortezomib in the management of multiple myeloma
  著者:: Laubach, Jacob P, 等
  出版事項: (2009)